P. Brust, W. Deuther-conrad, K. Lehmkuhl, H. Jia, and B. Wünsch, Molecular Imaging of ?1 Receptors in vivo: Current Status and Perspectives, Curr. Med. Chem, 2013.

S. Fischer, C. Wiese, G. Maestrup, E. Hiller, A. Deuther-conrad et al., Molecular imaging of ?? receptors: synthesis and evaluation of the potent ??1 selective radioligand [18F]fluspidine, European Journal of Nuclear Medicine and Molecular Imaging, vol.118, issue.3, pp.540-551, 2011.
DOI : 10.1111/j.1432-1033.1981.tb05561.x

G. Maestrup, E. Wiese, C. Schepmann, D. Brust, P. Wünsch et al., Synthesis, pharmacological activity and structure affinity relationships of spirocyclic ??1 receptor ligands with a (2-fluoroethyl) residue in 3-position, Bioorganic & Medicinal Chemistry, vol.19, issue.1, pp.393-405, 2011.
DOI : 10.1016/j.bmc.2010.11.013

G. Maestrup, E. Fischer, S. Wiese, C. Schepmann, D. Hiller et al., Receptor Ligands for Neuroimaging with Positron Emission Tomography, Journal of Medicinal Chemistry, vol.52, issue.19, pp.6062-6072, 2009.
DOI : 10.1021/jm900909e

G. Maestrup, E. Wiese, C. Schepmann, D. Hiller, A. Fischer et al., Synthesis of spirocyclic ??1 receptor ligands as potential PET radiotracers, structure???affinity relationships and in vitro metabolic stability, Bioorganic & Medicinal Chemistry, vol.17, issue.10, pp.3630-3641, 2009.
DOI : 10.1016/j.bmc.2009.03.060

T. Hayashi, S. Tsai, T. Mori, M. Fujimoto, and T. Su, Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders, Expert Opinion on Therapeutic Targets, vol.18, issue.3, pp.557-577, 2011.
DOI : 10.1097/00004714-199806000-00005

J. C. Hung, Comparison of various requirements of the quality assurance procedures for [18F]-FDG injection, J. Nucl. Med, vol.43, pp.1495-1506, 2002.

M. Ishikawa, K. Ishiwata, K. Ishii, Y. Kimura, M. Sakata et al., High Occupancy of Sigma-1 Receptors in the Human Brain after Single Oral Administration of Fluvoxamine: A Positron Emission Tomography Study Using [11C]SA4503, Biological Psychiatry, vol.62, issue.8, pp.878-883, 2007.
DOI : 10.1016/j.biopsych.2007.04.001

R. Kekuda, P. D. Prasad, Y. J. Fei, F. H. Leibach, and V. Ganapathy, Cloning and Functional Expression of the Human Type 1 Sigma Receptor (hSigmaR1), Biochemical and Biophysical Research Communications, vol.229, issue.2, pp.553-558, 1996.
DOI : 10.1006/bbrc.1996.1842

Y. Kimura, M. Naganawa, M. Sakata, M. Ishikawa, M. Mishina et al., Distribution volume as an alternative to the binding potential for sigma1 receptor imaging, Annals of Nuclear Medicine, vol.22, issue.9, pp.533-535, 2007.
DOI : 10.1038/jcbfm.1991.130

K. Kitaichi, J. G. Chabot, F. F. Moebius, A. Flandorfer, H. Glossmann et al., Expression of the purported sigma1 (??1) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy, Journal of Chemical Neuroanatomy, vol.20, issue.3-4, pp.375-387, 2000.
DOI : 10.1016/S0891-0618(00)00106-X

A. Maisonial, G. Maestrup, E. Wiese, C. Hiller, A. Schepmann et al., Synthesis, radiofluorination and pharmacological evaluation of a fluoromethyl spirocyclic PET tracer for central ??1 receptors and comparison with fluoroalkyl homologs, Bioorganic & Medicinal Chemistry, vol.20, issue.1, pp.257-269, 2012.
DOI : 10.1016/j.bmc.2011.11.002

URL : https://hal.archives-ouvertes.fr/hal-01677635

A. Maisonial, G. Maestrup, E. Fischer, S. Hiller, A. Scheunemann et al., A 18F-Labeled Fluorobutyl-Substituted Spirocyclic Piperidine Derivative as a Selective Radioligand for PET Imaging of Sigma1 Receptors, ChemMedChem, vol.22, issue.8, pp.1401-1410, 2011.
DOI : 10.1016/0006-2952(73)90196-2

URL : https://hal.archives-ouvertes.fr/hal-01677661

W. R. Martin, C. G. Eades, J. A. Thompson, R. E. Huppler, and P. E. Gilbert, The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther, vol.197, pp.517-532, 1976.

U. D. Neue, C. H. Phoebe, K. Tran, Y. F. Cheng, and Z. Lu, Dependence of reversed-phase retention of ionizable analytes on pH, concentration of organic solvent and silanol activity, Journal of Chromatography A, vol.925, issue.1-2, pp.49-67, 2001.
DOI : 10.1016/S0021-9673(01)01009-3

M. Sakata, Y. Kimura, M. Naganawa, K. Oda, K. Ishii et al., Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503, NeuroImage, vol.35, issue.1, pp.1-8, 2007.
DOI : 10.1016/j.neuroimage.2006.11.055

T. P. Su, T. Hayashi, T. Maurice, S. Buch, and A. E. Ruoho, The sigma-1 receptor chaperone as an inter-organelle signaling modulator, Trends in Pharmacological Sciences, vol.31, issue.12, pp.557-566, 2010.
DOI : 10.1016/j.tips.2010.08.007

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993063/pdf

J. Toyohara, M. Sakata, and K. Ishiwata, Imaging of Sigma1 Receptors in the Human Brain Using PET and [11C]SA4503, Central Nervous System Agents in Medicinal Chemistry, vol.9, issue.3, pp.190-196, 2009.
DOI : 10.2174/1871524910909030190

A. Van-waarde, N. K. Ramakrishnan, A. A. Rybczynska, P. H. Elsinga, K. Ishiwata et al., The cholinergic system, sigma-1 receptors and cognition, Behavioural Brain Research, vol.221, issue.2, pp.543-554, 2010.
DOI : 10.1016/j.bbr.2009.12.043

B. Wenzel, S. Fischer, P. Brust, and J. Steinbach, Accessible silanol sites ??? Beneficial for the RP-HPLC separation of constitutional and diastereomeric azaspirovesamicol isomers, Journal of Chromatography A, vol.1217, issue.50, pp.7884-7890, 2010.
DOI : 10.1016/j.chroma.2010.10.061